CHICAGO – October 16, 2026 -- Eleven vendors are new or returning on Tercera's fifth annual Tercera 30 ranking, the most turnover the growth equity firm has recorded in its Market Anchors category, as Anthropic, OpenAI and Palantir join that group for the first time.

The 2026-2027 list ranks the software and AI vendors and partner ecosystems with the greatest services growth potential for IT services firms. Tercera, an investment and advisory firm for AI and technology service firms, said the list reflects the shift across IT services in the AI era.

Single-vendor focus halves to 5% of IT services firms in Tercera survey

In Tercera's July 2026 survey of 378 technology services leaders, only 5% of firms focused on a single software partner, down from 10% a year earlier. Firms are moving away from single-vendor platform implementations. They now orchestrate data, systems and agents around domain processes and defined business outcomes.

Marietta – October 16, 2026 -- Lockheed Martin (NYSE:LMT) delivered the first C-130J-30 Super Hercules for the U.S. Navy's Take Charge and Move Out (TACAMO) mission on Oct. 15 at its Marietta, Georgia, facility. The aircraft will be modified into the E-130J Phoenix II, the Navy's next-generation airborne nuclear command-and-control platform.

Northrop Grumman to complete the E-130J conversion as mission systems integrator

The airframe will be transferred to Northrop Grumman, the mission systems integrator. The E-130J TACAMO industry team will then complete the conversion before the aircraft enters service as the E-130J Phoenix II.

Capt. Roger Davis, program manager for Airborne Strategic Command, Control and Communications (PMA-271), said the Navy now moves into mission systems integration. He described the delivered airframe as the structural and performance backbone for the mission.

Stuart, Fla. – October 16, 2026 -- Health In Tech, Inc. (Nasdaq: HIT) will hold its 2026 Annual Meeting of Stockholders on Tuesday, November 10, 2026, at 10:00 AM ET via live virtual webcast.

Stockholders of record as of Sept. 18 can vote and submit questions electronically

Holders of Health In Tech stock at the close of business on September 18, 2026, the Record Date, are eligible to vote their shares electronically during the meeting. They can also submit questions live during the session.

Eligible stockholders join through the company's designated virtual meeting portal at cleartrustonline.com/HIT.

Guests can attend in listen-only mode without a control number

Non-stockholders may access the 2026 Annual Meeting in listen-only mode. Guests do not need a control number to join.

Atlanta – October 16, 2026 -- The U.S. Food and Drug Administration (FDA) has approved a once-daily autoinjector for UCB's ZILBRYSQ (zilucoplan), with complete dose delivery in 99.8% of 449 administrations, UCB said. Commercial availability is expected in Q1 2027.

The device is cleared for adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. UCB (Euronext Brussels: UCB) describes ZILBRYSQ as the first and only macrocyclic peptide C5 inhibitor approved as a self-administered, once-daily subcutaneous autoinjector for gMG in the U.S.

Autoinjector adds a second self-administration route alongside the prefilled syringe

Before this approval, ZILBRYSQ was available only as a self-administered prefilled syringe (PFS). The autoinjector automatically delivers a pre-defined dose when activated against the skin. Patients or their care partners now have two portable options.

St. Petersburg, Florida – October 16, 2026 -- Attilio, a longevity platform launched in September 2026, has appointed Dr. Eric Verdin, President and CEO of the Buck Institute for Research on Aging, as Co-Chairman. The company prices the Dr. Verdin Baseline Assessment(TM), built on his research, at $2,500 per member.

Verdin brings Buck Institute research access to Attilio's care model

The Buck Institute describes itself as the first independent biomedical research institute focused solely on aging and age-related disease. Founded in Novato, California, it helped establish the field known as geroscience.

Los Angeles – October 16, 2026 -- TORL BioTherapeutics has appointed Sandip Kapadia as Chief Financial Officer, a executive who has raised more than $2 billion in public capital for emerging biotechnology companies, and Eric Sievers, M.D., as Chief Medical Officer, completing a year-long expansion of its leadership team.

TORL prepares lead antibody-drug conjugate for late-stage development

The clinical-stage oncology company is advancing its antibody-based portfolio toward late-stage development and potential commercialization. Its lead asset, ixotatug vedotin (Ixo-V), is being evaluated in platinum-resistant ovarian cancer and other cancers that express CLDN6, including germ cell tumors, and in various combinations. Ixo-V has FDA Fast Track designation.

TORL describes Ixo-V as the first and only antibody-drug conjugate (ADC) that selectively targets Claudin 6 (CLDN6) using a proven monomethyl auristatin E (MMAE) linker-payload construct.

Bogotá – October 16, 2026 -- NG Energy International Corp. expects total gross production at its Maria Conchita block in Colombia to rise to 23.0 MMcf/d from 16.0 MMcf/d after the Aruchara-6 well tested at up to 8.7 MMcf/d gross and entered production.

Aruchara-6 flows at 8.7 MMcf/d gross through the central processing facility

The well was drilled to a total depth of 9,352 feet and hit the H1 target as designed. It also passed through the H2, H3, H4, H5 and H6 zones, all of which showed gas at surface and on wireline logs. During initial flow testing through the central processing facility (CPF), Aruchara-6 produced up to 8.7 MMcf/d gross (6.96 MMcf/d net) on a 30/64 choke at an average tubing head pressure of 780 psi.

Chicago – October 16, 2026 -- Keeper Security has launched native integrations with Tenable that let cloud security teams remediate findings in seconds rather than the days or weeks manual workflows typically take, and that move static scan credentials out of Tenable policies into Keeper.

The integrations are available now to Keeper customers with active KeeperPAM licenses.

Tenable findings feed directly into Keeper's remediation engine

Cloud findings from Tenable now go straight into Keeper's remediation engine. Security teams can rotate credentials, enforce Just-In-Time (JIT) access and remove standing privileges without leaving the Keeper platform. Once remediation is complete, Keeper notifies Tenable and moves the finding to resolved status, with no manual follow-up or ticket management.

Las Vegas – October 16, 2026 -- Rareview Capital LLC and Tuttle Capital Management have launched the Tuttle - Rareview Humanoid Robotics ETF (HOID), an actively managed fund that targets both humanoid robot developers and the technologies inside them.

HOID splits the robotics supply chain into "Brains" and "Body"

The strategy covers the "Brains": artificial intelligence, software and semiconductors. It also covers the "Body": sensors, actuators, batteries and other essential components. The fund extends beyond robot manufacturers to the suppliers behind them.

HOID may hold U.S. and international companies. These include firms in commercial production and those building fully functional prototypes that are moving toward commercialization. Portfolio weights are rebalanced at least quarterly.

HOUSTON – October 16, 2026 -- MSC Income Fund, Inc. (NYSE: MSIF) will release its third quarter 2026 results on Thursday, November 5, 2026, after the financial markets close, the Houston-based fund said on October 16.

MSC Income Fund schedules Q3 call for November 6 at 11:00 a.m. Eastern

Management will hold a conference call on Friday, November 6, 2026, at 11:00 a.m. Eastern time, the morning after the release. The call will be broadcast live by phone and over the Internet, and investors can join by phone or audio webcast.

Fund discloses no financial metrics ahead of the release

The announcement gives no preliminary figures, guidance or portfolio data for the quarter. Investors will have to wait for the November 5 release for results.